Fungating lesion: Difference between revisions
m clean up using AWB |
DocWatson42 (talk | contribs) Performed minor cleanup. Tags: Mobile edit Mobile web edit Advanced mobile edit |
||
| (8 intermediate revisions by 8 users not shown) | |||
| Line 1: | Line 1: | ||
{{Short description|Type of skin lesion}} |
|||
| ⚫ | A '''fungating lesion''' is a |
||
| ⚫ | A '''fungating lesion''' is a [[skin lesion]] that [[wikt:fungate#Verb|fungates]], that is, becomes like a [[fungus]] in its appearance or growth rate. It is marked by [[ulcer (dermatology)|ulceration]]s (breaks on the skin or surface of an organ) and [[necrosis]] (death of living tissue) and usually presents a foul odor. This kind of lesion may occur in many types of [[cancer]], including [[breast cancer]], [[melanoma]], and [[squamous cell carcinoma]], and especially in advanced disease. The characteristic malodorous smell is caused by [[dimethyl trisulfide]].<ref name=Shirasu2009>{{cite journal | vauthors = Shirasu M, Nagai S, Hayashi R, Ochiai A, Touhara K | s2cid = 28235413 | title = Dimethyl trisulfide as a characteristic odor associated with fungating cancer wounds | journal = Bioscience, Biotechnology, and Biochemistry | volume = 73 | issue = 9 | pages = 2117–20 | date = September 2009 | pmid = 19734656 | doi = 10.1271/bbb.90229 }}</ref> It is usually not a [[mycosis|fungal infection]] but rather a [[Neoplasm|neoplastic growth]] with necrosing portions. |
||
There is a weak evidence that 6% [[miltefosine]] solution applied topically on superficial fungating breast lesions of less than 1 cm in size, on patients who received previous radiotherapy, surgery, hormonal therapy or chemotherapy for their breast cancer, may slow the disease progression.<ref>{{cite journal | vauthors = Adderley UJ, Holt IG | title = Topical agents and dressings for fungating wounds | journal = The Cochrane Database of Systematic Reviews | issue = 5 | pages = CD003948 | date = May 2014 | pmid = 24832784 | pmc = 6464725 | doi = 10.1002/14651858.CD003948.pub3 | collaboration = Cochrane Wounds Group }}</ref> |
|||
== References == |
== References == |
||
| Line 12: | Line 16: | ||
[[Category:Dermatologic terminology]] |
[[Category:Dermatologic terminology]] |
||
[[Category:Oncology]] |
[[Category:Oncology]] |
||
{{oncology-stub}} |
{{oncology-stub}} |
||
Latest revision as of 10:41, 14 October 2024
A fungating lesion is a skin lesion that fungates, that is, becomes like a fungus in its appearance or growth rate. It is marked by ulcerations (breaks on the skin or surface of an organ) and necrosis (death of living tissue) and usually presents a foul odor. This kind of lesion may occur in many types of cancer, including breast cancer, melanoma, and squamous cell carcinoma, and especially in advanced disease. The characteristic malodorous smell is caused by dimethyl trisulfide.[1] It is usually not a fungal infection but rather a neoplastic growth with necrosing portions.
There is a weak evidence that 6% miltefosine solution applied topically on superficial fungating breast lesions of less than 1 cm in size, on patients who received previous radiotherapy, surgery, hormonal therapy or chemotherapy for their breast cancer, may slow the disease progression.[2]
References
[edit]- ^ Shirasu M, Nagai S, Hayashi R, Ochiai A, Touhara K (September 2009). "Dimethyl trisulfide as a characteristic odor associated with fungating cancer wounds". Bioscience, Biotechnology, and Biochemistry. 73 (9): 2117–20. doi:10.1271/bbb.90229. PMID 19734656. S2CID 28235413.
- ^ Adderley UJ, Holt IG, et al. (Cochrane Wounds Group) (May 2014). "Topical agents and dressings for fungating wounds". The Cochrane Database of Systematic Reviews (5): CD003948. doi:10.1002/14651858.CD003948.pub3. PMC 6464725. PMID 24832784.
External links
[edit]
This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.
 | This oncology article is a stub. You can help Wikipedia by expanding it. |